Headlands Research completes acquisition of Pharmasite Research, expanding expertise in mental health and CNS research
Mar 01, 2024•almost 2 years ago
Acquiring Company
Headlands
Acquired Company
Pharmasite Research
Description
Headlands Research, a multinational network of clinical trial sites, has completed the acquisition of Pharmasite Research, an established clinical trial site dedicated to research in mental illness and disorders of the central nervous system (CNS). This strategic acquisition enhances Headlands Research's therapeutic expertise in key competencies, reinforcing its commitment to advancing innovative medical therapies.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed